Home › NDC Lookup › RxCUI directory › RxCUI 352201

Olmesartan medoxomil 40 MG Oral Tablet [Benicar] — RxCUI 352201

Name: Olmesartan medoxomil 40 MG Oral Tablet [Benicar] (RxCUI 352201)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 352201 Semantic branded drug · SBD ● Current RxNorm concept 6 FDA products 6 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI352201

Official nameOlmesartan medoxomil 40 MG Oral Tablet [Benicar]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asBenicar 40 MG Oral Tablet

FDA products mapped6

Package NDCs mapped6

Reported Medicaid activity (SDUD)134 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Olmesartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Olmesartan is used to treat high blood pressure — also called hypertension — in adults and in kids as young as 6. Keeping your blood pressure in a healthy range matters because unc...
Nope — food doesn't change how well olmesartan is absorbed, so you can take it with or without a meal. What matters most is taking it at the same time every day so your blood press...
Does it matter if I take olmesartan with food or on an empty stomach?
The most common one is dizziness, especially when you first start or if you stand up quickly. That usually settles down as your body adjusts. The things that warrant a call to your...

📖 Read our full Olmesartan guide →

🕸️ Concept Web — How Olmesartan medoxomil 40 MG Oral Tablet [Benicar] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Olmesartan medoxomil 40 MG Oral Tablet [Benicar] RxCUI 352201 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Olmesartan 321064 IN
- Olmesartan medoxomil 118463 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Benicar 327503 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Olmesartan Oral Tablet 378991 SCDF
- Olmesartan medoxomil Oral Tablet 2646044 SCDFP
- Olmesartan Oral Product 1159559 SCDG
- Olmesartan Pill 1159560 SCDG
- Olmesartan medoxomil Oral Product 2663366 SCDGP
- Olmesartan medoxomil Pill 2660825 SCDGP
- Olmesartan Oral Tablet [Benicar] 369419 SBDF
- Olmesartan medoxomil Oral Tablet [Benicar] 2655442 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Olmesartan medoxomil 40 MG Oral Tablet 349405 SCD
- Olmesartan medoxomil 40 MG 359114 SCDC
- Olmesartan medoxomil 40 MG [Benicar] 575928 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Olmesartan medoxomil 40 MG Oral Tablet SCD · 349405
Olmesartan medoxomil 40 MG SCDC · 359114
Olmesartan Oral Tablet SCDF · 378991
Olmesartan medoxomil Oral Tablet SCDFP · 2646044
Olmesartan Oral Product SCDG · 1159559
Olmesartan Pill SCDG · 1159560
Olmesartan medoxomil Oral Product SCDGP · 2663366
Olmesartan medoxomil Pill SCDGP · 2660825

Brand-Name Concepts

Olmesartan medoxomil 40 MG [Benicar] SBDC · 575928
Olmesartan Oral Tablet [Benicar] SBDF · 369419
Olmesartan medoxomil Oral Tablet [Benicar] SBDFP · 2655442
Benicar Oral Product SBDG · 1170823
Benicar Pill SBDG · 1171463
Benicar BN · 327503

📦 FDA Products & Package NDCs

6 products · 6 package NDCs

6 package NDCs map to RxCUI 352201 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00713-0860-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0860-30)	Benicar	Cosette Pharmaceuticals, Inc.	2022-09-01
00713-0861-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0861-30)	Benicar	Cosette Pharmaceuticals, Inc.	2022-09-01
00713-0862-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0862-30)	Benicar	Cosette Pharmaceuticals, Inc.	2022-09-01
00713-0940-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0940-30)	Benicar	Cosette Pharmaceuticals, Inc.	2025-10-01
00713-0941-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0941-30)	Benicar	Cosette Pharmaceuticals, Inc.	2025-08-01
00713-0942-30	30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0713-0942-30)	Benicar	Cosette Pharmaceuticals, Inc.	2025-12-01

Observed labelers: Cosette Pharmaceuticals, Inc. (6) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.